Clinical Trial

REsponse to Combined SONS and ONS in Chronic Cluster headachE

Study acronym: RESPONSE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to demonstrate the safe use of the PRIMUS System in subjects with chronic cluster headache. This is a single-centre, open label, prospective, first in human study to collect initial clinical data on the PRIMUS system for the treatment of chronic cluster headache.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-05-11; most recent amendment 2026-04-22.
Status change: Recruiting → Active, Not Recruiting 2024-11-26
Trial Details
NCT Number NCT05868044
Lead Sponsor Salvia BioElectronics
Conditions Chronic Cluster Headache
Enrollment 5 participants
Start Date 2023-05-02
Primary Completion 2024-04-23 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-23